| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.5 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.46 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |